Mahyar Toofantabrizi, | |
9000 Franklin Square Dr, Baltimore, MD 21237-3901 | |
(443) 777-7000 | |
Not Available |
Full Name | Mahyar Toofantabrizi |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 19 Years |
Location | 9000 Franklin Square Dr, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043770837 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | D0093591 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Thanks to vaccination, polio has been pushed to the brink of extinction - but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.
Training physicians and caregivers to improve cultural sensitivity and communication with economically disadvantaged African-American patients could influence these women to get mammograms that could save their lives, according to a new study in the Journal of General Internal Medicine.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft ("Augment"), to autograft for use in hindfoot and ankle fusion surgery.
› Verified 5 days ago
Entity Name | Medstar Medical Group Ii Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
Thanks to vaccination, polio has been pushed to the brink of extinction - but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.
Training physicians and caregivers to improve cultural sensitivity and communication with economically disadvantaged African-American patients could influence these women to get mammograms that could save their lives, according to a new study in the Journal of General Internal Medicine.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft ("Augment"), to autograft for use in hindfoot and ankle fusion surgery.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mahyar Toofantabrizi, 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 | Mahyar Toofantabrizi, 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 |
News Archive
Thanks to vaccination, polio has been pushed to the brink of extinction - but can we finish the job? This is one of the big questions which a Bristol academic addresses in his new book, published next week.
Training physicians and caregivers to improve cultural sensitivity and communication with economically disadvantaged African-American patients could influence these women to get mammograms that could save their lives, according to a new study in the Journal of General Internal Medicine.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.
BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft ("Augment"), to autograft for use in hindfoot and ankle fusion surgery.
› Verified 5 days ago
Allison Weaver, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe Street, Meyer 8-134, Baltimore, MD 21287 Phone: 410-614-4474 Fax: 410-367-2770 | |
Cheryl Myers Hepp, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-2882 Fax: 410-328-7607 | |
Omid Sanaei, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2284 Fax: 410-554-2184 | |
Sumedha Nallamothu, M.B.B.S Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe Street, Meyer 8-134, Baltimore, MD 21287 Phone: 410-614-4474 Fax: 410-367-2770 | |
Dr. Nejat Ahmed Mohammed, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3001 S Hanover St, Baltimore, MD 21225 Phone: 410-350-3200 | |
Lee-ann Marie Wagner, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-2882 Fax: 410-328-7607 |